Literature DB >> 11311483

Androgen regulation of CYP4B1 responsible for mutagenic activation of bladder carcinogens in the rat bladder: detection of CYP4B1 mRNA by competitive reverse transcription-polymerase chain reaction.

S Imaoka1, Y Yoneda, T Sugimoto, S Ikemoto, T Hiroi, K Yamamoto, T Nakatani, Y Funae.   

Abstract

Significant sex differences exist among cases of bladder cancer in humans as well as in experimental animals such as rats. Aromatic amines such as benzidine and 2-naphthylamine are known to induce bladder cancer. These carcinogenic amines are activated to genotoxic substances by cytochrome P 450 CYP4B1, which is present in bladder mucosa. In this study, regulation of CYP4B1 was investigated to elucidate sex difference in bladder carcinogenesis. Competitive reverse transcription-polymerase chain reaction was used to investigate the expression of rat CYP4B1 mRNA occurring in small amounts of tissue such as bladder tissue. Expression of CYP4B1 in the bladder of male rats increased with development but not in that of female rats. Moreover, mature male rats exhibited higher expression of CYP4B1 in the bladder than did mature female rats. Castration of male rats decreased CYP4B1 levels and treatment with testosterone led to a partial recovery of CYP4B1 levels. These results indicate that CYP4B1 levels in the rat bladder are partly regulated by androgens. Furthermore, the present findings suggest that the sex difference observed in bladder carcinogenesis was due to sex-different expression of CYP4B1 in bladder tissue.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11311483     DOI: 10.1016/s0304-3835(00)00572-3

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  7 in total

Review 1.  Understanding the gender disparity in bladder cancer risk: the impact of sex hormones and liver on bladder susceptibility to carcinogens.

Authors:  Yuesheng Zhang
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2013       Impact factor: 3.781

Review 2.  Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forward.

Authors:  Andrea B Apolo; Vanessa Hoffman; Matthew G Kaag; David M Latini; Cheryl T Lee; Jonathan E Rosenberg; Margaret Knowles; Dan Theodorescu; Bogdan A Czerniak; Jason A Efstathiou; Matthew L Albert; Srikala S Sridhar; Vitaly Margulis; Surena F Matin; Matthew D Galsky; Donna Hansel; Ashish M Kamat; Thomas W Flaig; Angela B Smith; Edward Messing; Diane Zipursky Quale; Yair Lotan
Journal:  Urol Oncol       Date:  2014-07-25       Impact factor: 3.498

3.  Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor.

Authors:  Jong-Wei Hsu; Iawen Hsu; Defeng Xu; Hiroshi Miyamoto; Liang Liang; Xue-Ru Wu; Chih-Rong Shyr; Chawnshang Chang
Journal:  Am J Pathol       Date:  2013-03-13       Impact factor: 4.307

4.  Enzalutamide as an androgen receptor inhibitor prevents urothelial tumorigenesis.

Authors:  Takashi Kawahara; Satoshi Inoue; Eiji Kashiwagi; Jinbo Chen; Hiroki Ide; Taichi Mizushima; Yi Li; Yichun Zheng; Hiroshi Miyamoto
Journal:  Am J Cancer Res       Date:  2017-10-01       Impact factor: 6.166

Review 5.  Androgen Receptor Signaling in Bladder Cancer.

Authors:  Peng Li; Jinbo Chen; Hiroshi Miyamoto
Journal:  Cancers (Basel)       Date:  2017-02-22       Impact factor: 6.639

6.  Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospondin-1.

Authors:  Aimee M Johnson; Mary J O'Connell; Hiroshi Miyamoto; Jiaoti Huang; Jorge L Yao; Edward M Messing; Jay E Reeder
Journal:  BMC Urol       Date:  2008-04-23       Impact factor: 2.264

Review 7.  Steroid Hormone Receptor Signals as Prognosticators for Urothelial Tumor.

Authors:  Hiroki Ide; Hiroshi Miyamoto
Journal:  Dis Markers       Date:  2015-12-07       Impact factor: 3.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.